Great opening paragraphs in this NLM article from Mikhail Blagosklonny. I like his philosophy here:
If you’re interested in reading the whole article, here’s the link:
4 Likes
He is asking for balancing of the future research investment vs what can be done now. In my mind the drug combinations that he mentioned including Rapamycin most likely will not extend the max potential human lifespan of 120 years. More likely they will extend an average health span and lifespan.so yes it is worth testing these drug combinations and any others that itp program, Kaeberlein and other researchers will uncover.
3 Likes